Gene · 92521
NIH grants1,071
NIH grants whose papers are about the gene, through NIH's grant-paper links.
481 to 500 of 1,071
Download this page as JSON| Grant | Title | SPECC1 papers | Newest fiscal year |
|---|---|---|---|
| U19AI171292 | RAPIDLY EMERGING ANTIVIRAL DRUG DEVELOPMENT INITIATIVE- AViDD CENTER (READDI-AC) | 2 | 2022 |
| U19AI171443 | Center for Antiviral Medicines & Pandemic Preparedness (CAMPP) | 2 | 2022 |
| F30CA250249 | Mechanosensation in tumorigenesis and metastasis | 1 | 2022 |
| F31AI164671 | Suppression of Host Antiviral Responses by a SARS-CoV-2 Histone Mimetic | 1 | 2022 |
| F32DK124963 | Investigating sex-specific metabolic effects of disrupted selenocysteine lyase and selenocysteine tRNA in Agrp hypothalamic neurons | 1 | 2022 |
| F99CA264422 | A visible machine learning system to discover targeted treatment solutions in cancer | 1 | 2022 |
| K01TW010853 | Identifying genetic determinants of Rotavirus Vaccine Failure in Malawian Children | 1 | 2022 |
| K08AI135072 | The Effect of Maternal Cells on Infant Immunity | 1 | 2022 |
| K23HL139987 | Microbiome-based diagnosis of pneumonia in the acute respiratory distress syndrome | 1 | 2022 |
| P01AI132122 | Molecular Determinants of Tissue-resident Memory T cell Fate in Acute and Chronic Infection | 1 | 2022 |
| P01CA193124 | Processing and Repair of DNA Crosslinks | 1 | 2022 |
| P20GM103648 | Oklahoma Center for Respiratory and Infectious Diseases | 1 | 2022 |
| P50DA044123 | Targeting cell signaling pathways to disrupt drug abuse | 1 | 2022 |
| R00GM124458 | Regulation of Ribosome Biogenesis During Stress | 1 | 2022 |
| R01AG061105 | A knowledge map to find Alzheimer's disease drugs | 1 | 2022 |
| R01AI050237 | Translation Regulation by Enterovirus Proteinase | 1 | 2022 |
| R01AI071002 | Developing Combination Therapies against Pneumo- and Paramyxoviruses Causing Severe Respiratory Infection | 1 | 2022 |
| R01AI121129 | Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites | 1 | 2022 |
| R01AI130222 | Leishmania RNA viruses and pathogenesis | 1 | 2022 |
| R01AI134732 | Development of Benzodiazepine YFV NS4B inhibitors as therapeutic agents for Yellow Fever | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/grants?page=25